Enoxaparin sodium
| Clinical data | |
|---|---|
| Trade names | Lovenox, Clexane, Xaparin, others |
| Biosimilars | Arovi, Axberi, Axberi HP, Exarane, Exarane Forte, Enoxapo, Inclunox, Inclunox HP, Inhixa, Noromby, Noromby HP, Redesca, Redesca HP, Thorinane |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a696006 |
| License data |
|
| Pregnancy category |
|
| Routes of administration | Subcutaneous, intravenous |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Elimination half-life | 4.5 hours |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.029.698 |
| Chemical and physical data | |
| Formula | (C26H40N2O36S5)n |
| Molar mass | 4500 g/mol (average) |
| (what is this?) (verify) | |
Enoxaparin sodium, sold under the brand name Lovenox among others, is an anticoagulant medication (blood thinner). It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. It is also used during hemodialysis.
Common side effects include bleeding, fever, and swelling of the legs. Bleeding may be serious especially in those who are undergoing a spinal tap. Use during pregnancy appears to be safe for the fetus. Enoxaparin is in the low molecular weight heparin family of medications.
Enoxaparin was first made in 1981 and approved for medical use in 1993. It is on the World Health Organization's List of Essential Medicines. Enoxaparin is sold under several brand names and is available as a generic medication. Enoxaparin is made from heparin. In 2020, it was the 350th most commonly prescribed medication in the United States, with more than 500 thousand prescriptions.